Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125444
Status:
RECRUITING
Last Update Posted:
2023-12-08
First Post:
2022-11-14
Brief Title:
Impact of Hyperuricemia on Psoriatic Arthritis
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
IImpact of Hyperuricemia on Psoriatic Arthritis
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Psoriatic
Brief Summary:
Psoriatic arthritis and gout linked to hyperuricemia are two rheumatisms well known to rheumatologists There are epidemiological and physiopathological arguments in favor of a non-fortuitous link between these two rheumatisms which to date has not been established There is currently no recommendation to treat hyperuricaemia without an episode of gout attack We hypothesize that there is a link between hyperuricemia and severity of rheumatism This would ultimately modify the therapeutic management of hyperuricemic patients followed for psoriatic arthritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None